Coverage: LD-2 reports for 2025 onward, posted Jan 1, 2025 through Oct 28, 2026. Only the current version of each report is used.
41,286 report citations, newest first.
NATIONAL ASSOCIATION OF HOME BUILDERS · lobbying firm or registrant: NATIONAL ASSOCIATION OF HOME BUILDERS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Disaster Planning/Emergencies
$1,160,000
Spent on own lobbying
CitesS. 1071· this member:Recorded votes on 3 roll calls
…ng Codes Flexibility, H.R.501/S.333 (the Promoting Resilient Buildings Act), H.R. 4669 (FEMA Act of 2025), H.R.1105 (The Disaster Resiliency and Coverage Act), S. 1071 (The National Defense Authorization Act for FY 26)
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
APTS ACTION INC · lobbying firm or registrant: APTS ACTION, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$300,000
Spent on own lobbying
CitesH.R. 4· this member:Recorded votes on 21 roll calls
Funding for public broadcasting's public safety work Funding for public broadcastings infrastructure H.R. 4, the Rescissions Act of 2025. Issue: Public broadcasting rescissions Cancelling of previously appropriated Ready To Learn Funding Freezing of previously approp…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EQUIFAX · lobbying firm or registrant: THOLOS GOVERNMENT RELATIONS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$70,000
Paid to lobbying firm
CitesS. 1892· this member:Cosponsored
H.R. 909/S. 1892-Crime Victims Fund Stabilization Act of 2025; Issues related to funding for the Victims of Crime Act (VOCA)
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$7,040,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 44 roll calls
H.R. 6500: Continuing Appropriations and Extensions Act, 2027 (Public Law 119-103) Presidents Budget Fiscal Year 2027 H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Ac…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$7,040,000
Spent on own lobbying
CitesH.R. 6500· this member:Recorded votes on 4 roll calls
H.R. 6500: Continuing Appropriations and Extensions Act, 2027 (Public Law 119-103) Presidents Budget Fiscal Year 2027 H.R. 1: One Big Beautiful Bill Act (Public Law 119-…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$7,040,000
Spent on own lobbying
CitesH.R. 6938· this member:Recorded votes on 3 roll calls
…man Services, and Education, and Related Agencies Appropriations Act, 2027 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (Public Law 119-74) S. 2354: Commerce, Justice…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$7,040,000
Spent on own lobbying
CitesH.R. 7148· this member:Recorded votes on 8 roll calls
…on Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authorization Act for Fiscal Year 2027 H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Inflation Reduction Act of 2022 (Public Law 117-169) implementation policy issues Government funding…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$7,040,000
Spent on own lobbying
CitesS. 1071· this member:Recorded votes on 3 roll calls
…t; and Interior and Environment Appropriations Act, 2026 (Public Law 119-74) S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: Nation…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$7,040,000
Spent on own lobbying
CitesS. 2296· this member:Recorded votes on 12 roll calls
…Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authoriza…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$7,040,000
Spent on own lobbying
CitesS. 4784· this member:Recorded vote on 1 roll call
…ar 2026 (Public Law 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authorization Act for Fiscal Year 2027 H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Inflation Reduction Act of 2022 (…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Copyright/Patent/Trademark
$7,040,000
Spent on own lobbying
CitesS. 1096· this member:Cosponsored
S. 43: Skinny Labels, Big Savings Act S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Re…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$7,040,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 44 roll calls
…S. 3788: CLEAR LABELS Act S. 3794: SAFE Drugs Act of 2026 S. 4189: INSULIN Act of 2026 S. 5043: Secure Drug Supply Chain Act of 2026 S. 5244: SUSTAIN 340B Act H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 946: ORPHAN Cures Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$7,040,000
Spent on own lobbying
CitesS. 4189· this member:Cosponsored
…Ensuring Timely Access to Generics Act of 2025 S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act S. 3794: SAFE Drugs Act of 2026 S. 4189: INSULIN Act of 2026 S. 5043: Secure Drug Supply Chain Act of 2026 S. 5244: SUSTAIN 340B Act H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 946: O…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$7,040,000
Spent on own lobbying
CitesS. 864· this member:Cosponsored
…Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 1387: National Biotechnology Initiative Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination A…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$7,040,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 44 roll calls
H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 4299: Protecting Patient Access to Cancer and Complex Therapies Act H.R. 10628: Biosimilars Access and Aff…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE OHIO STATE UNIVERSITY · lobbying firm or registrant: THE OHIO STATE UNIVERSITY
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Education
$90,115
Spent on own lobbying
CitesS. 2511· this member:Cosponsored
…4.016A); International Research and Studies (84.017A); Centers for International Business Education (84.220A); Language Resource Centers (84.229A). - H.R. 4806/S. 2511 "The College Transparency Act"; All provisions. - H.R. 9896, the Workforce Innovation for Next-Gen Growth in Skies (WINGS) Act of 2026; All provisions. - H.R.…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE OHIO STATE UNIVERSITY · lobbying firm or registrant: THE OHIO STATE UNIVERSITY
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Sports/Athletics
$90,115
Spent on own lobbying
CitesS. 4668· this member:Recorded votes on 11 roll calls
- General issues related to Name, Image, Likeness in collegiate athletics. - S. 4668, the Protect College Sports Act; All provisions.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CENTER FOR AI SAFETY ACTION FUND, INC. · lobbying firm or registrant: CENTER FOR AI SAFETY ACTION FUND, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · amended · posted Oct 20, 2026 · issue area: Defense
$60,000
Spent on own lobbying
CitesS. 2296· this member:Recorded votes on 12 roll calls
S. 2296: National Defense Authorization Act for Fiscal Year 2026; provisions related to artificial intelligence policy
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CENTER FOR AI SAFETY ACTION FUND, INC. · lobbying firm or registrant: CENTER FOR AI SAFETY ACTION FUND, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · amended · posted Oct 20, 2026 · issue area: Trade (domestic/foreign)
$60,000
Spent on own lobbying
CitesS. 1705· this member:Cosponsored
H.R. 3447: Chip Security Act; provisions related to AI and national security policy S. 1705: Chip Security Act; provisions related to AI and national security policy
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CHUBB INA HOLDINGS INC. · lobbying firm or registrant: CHUBB INA HOLDINGS INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Insurance
$410,000
Spent on own lobbying
CitesS. 570· this member:Sponsored
…e coverage for various natural catastophes. Issues related to the National Flood Insurance Program (NFIP). Issues related to cannabis safe harbor for insurers. S. 570 / H.R. 1285 - Water Infrastructure Subcontractor and Taxpayer Protection Act. Issues related to Artificial Intelligence. H.R.7130 - McCarran-Ferguson Restorati…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUNTORY GLOBAL SPIRITS (FORMERLY BEAM SUNTORY INC.) · lobbying firm or registrant: THE WASHINGTON TAX & PUBLIC POLICY GROUP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Agriculture
$30,000
Paid to lobbying firm
CitesH.R. 6500· this member:Recorded votes on 4 roll calls
Issues related to S.Amdt. 6747 to H.R. 6500 - Continuing Appropriations and Extensions Act, 2027 (P.L. 119-103)
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL MINING ASSOCIATION · lobbying firm or registrant: NATIONAL MINING ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Defense
$700,000
Spent on own lobbying
CitesS. 4784· this member:Recorded vote on 1 roll call
Defense Minerals and Energy Supply Chains and Stockpiling H.R. 8800 / S. 4784, National Defense Authorization for Fiscal Year 2027, Multiple Titles Defense Industrial Base Loans and Grants
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL MINING ASSOCIATION · lobbying firm or registrant: NATIONAL MINING ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Natural Resources
$700,000
Spent on own lobbying
CitesS. 1130· this member:Cosponsored
S. 1130 / H.R. 2457, Mining Schools Act, All Titles S. 544 / H.R. 1366, Mining Regulatory Clarity Act, All Titles S. 859 / H.R. 1865, Mining Waste, Fraud, and Abuse Pr…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL MINING ASSOCIATION · lobbying firm or registrant: NATIONAL MINING ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Trade (domestic/foreign)
$700,000
Spent on own lobbying
CitesH.R. 5334· this member:Recorded votes on 4 roll calls
…ritical Energies (DOMINANCE) Act, All Titles S. 4392, Energy Security Pacts Act, All Titles S. 3772, Export-Import Bank Reauthorization Act of 2026, All Titles H.R. 5334, Lindsey O. Graham Sanctioning Russia and Iran Act of 2026, All Titles
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL MINING ASSOCIATION · lobbying firm or registrant: NATIONAL MINING ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Waste (hazardous/solid/interstate/nuclear)
$700,000
Spent on own lobbying
CitesS. 2741· this member:Sponsored
H.R. 3713 / S. 2741, Legacy Mine Cleanup Act, All Titles H.R. 9616, Environmental Monitoring and Remediation Technology Assessment Initiative Authorization Act (EMRTAI), All Title…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
